Imugene Limited

Industry

  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
    • Specialty Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy

Other Names/Subsidiaries

  • BioMimic Technologies
  • Biolife Science
  • Brightsun Investments
  • Lingual Consegna
  • Paragen
  • Vaxinia
  • Vectogen
See more in Biomedtracker

Latest on Imugene Limited

Scrip

Precision Sells Off Autoimmune Rights For Allogeneic CAR-T To TG Therapeutics

 
• By Alaric DeArment

As sales of its CD20-directed monoclonal antibody for multiple sclerosis pick up speed, TG Therapeutics, Inc. is furthering its pivot from oncology into immunology through a deal with Precision Bio

Scrip

Deal Watch: Lilly Sends European Commercial Rights For Two Migraine Drugs To Organon

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R

Scrip

Deal Watch: Leo Pharma Adds Rare Dermatology Disorder Candidate In Timber Buyout

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Leo To Pay $14m For Timber, Plus Milest

Scrip

Allo CAR-T Is Still On The Shelf As Precision Moves On

 
• By Andrew McConaghie

Precision BioSciences , which had hoped to be the first company to bring an allogeneic CAR-T to market, has announced its exit from the field with the sale of its lead asset, azercabtagene zapreleucel